Similar articles for PMID: 22525682

Year	Number of Results
1961	1
1966	1
1968	1
1980	2
1983	3
1984	1
2002	1
2003	2
2005	2
2006	4
2007	5
2008	3
2009	2
2010	5
2011	7
2012	7
2013	5
2014	4
2015	9
2016	4
2017	4
2018	2
2019	7
2020	1
2024	0

1

Kavalactones and the endocannabinoid system: the plant-derived yangonin is a novel CB₁ receptor ligand.

Ligresti A, Villano R, Allarà M, Ujváry I, Di Marzo V. Ligresti A, et al. Pharmacol Res. 2012 Aug;66(2):163-9. doi: 10.1016/j.phrs.2012.04.003. Epub 2012 Apr 14. Pharmacol Res. 2012. PMID: 22525682

2

FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels.

Petrosino S, Di Marzo V. Petrosino S, et al. Curr Opin Investig Drugs. 2010 Jan;11(1):51-62. Curr Opin Investig Drugs. 2010. PMID: 20047159 Review.

3

Interaction of ligands for the peroxisome proliferator-activated receptor gamma with the endocannabinoid system.

Lenman A, Fowler CJ. Lenman A, et al. Br J Pharmacol. 2007 Aug;151(8):1343-51. doi: 10.1038/sj.bjp.0707352. Epub 2007 Jun 25. Br J Pharmacol. 2007. PMID: 17592505 Free PMC article.

4

Fatty acid amide hydrolase and monoacylglycerol lipase inhibitors produce anti-allodynic effects in mice through distinct cannabinoid receptor mechanisms.

Kinsey SG, Long JZ, Cravatt BF, Lichtman AH. Kinsey SG, et al. J Pain. 2010 Dec;11(12):1420-8. doi: 10.1016/j.jpain.2010.04.001. Epub 2010 Jun 16. J Pain. 2010. PMID: 20554481 Free PMC article.

5

Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system.

Saario SM, Poso A, Juvonen RO, Järvinen T, Salo-Ahen OM. Saario SM, et al. J Med Chem. 2006 Jul 27;49(15):4650-6. doi: 10.1021/jm060394q. J Med Chem. 2006. PMID: 16854070

6

Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist.

Brizzi A, Aiello F, Marini P, Cascio MG, Corelli F, Brizzi V, De Petrocellis L, Ligresti A, Luongo L, Lamponi S, Maione S, Pertwee RG, Di Marzo V. Brizzi A, et al. Bioorg Med Chem. 2014 Sep 1;22(17):4770-83. doi: 10.1016/j.bmc.2014.07.006. Epub 2014 Jul 12. Bioorg Med Chem. 2014. PMID: 25065940

7

Novel natural and synthetic ligands of the endocannabinoid system.

Hanus LO, Mechoulam R. Hanus LO, et al. Curr Med Chem. 2010;17(14):1341-59. doi: 10.2174/092986710790980096. Curr Med Chem. 2010. PMID: 20166928 Review.

8

Loratadine analogues as MAGL inhibitors.

Patel JZ, Ahenkorah S, Vaara M, Staszewski M, Adams Y, Laitinen T, Navia-Paldanius D, Parkkari T, Savinainen JR, Walczyński K, Laitinen JT, Nevalainen TJ. Patel JZ, et al. Bioorg Med Chem Lett. 2015 Apr 1;25(7):1436-42. doi: 10.1016/j.bmcl.2015.02.037. Epub 2015 Feb 24. Bioorg Med Chem Lett. 2015. PMID: 25752982

9

Modulation of the endocannabinoid system by the fatty acid amide hydrolase, monoacylglycerol and diacylglycerol lipase inhibitors as an attractive target for secretory diarrhoea therapy.

Wasilewski A, Misicka A, Sacharczuk M, Fichna J. Wasilewski A, et al. J Physiol Pharmacol. 2017 Aug;68(4):591-596. J Physiol Pharmacol. 2017. PMID: 29151076 Free article.

10

Endocannabinoid-hydrolysing enzymes in the post-mortem cerebellum of humans affected by hereditary autosomal dominant ataxias.

Rodríguez-Cueto C, Benito C, Romero J, Hernández-Gálvez M, Gómez-Ruiz M, Fernández-Ruiz J. Rodríguez-Cueto C, et al. Pathobiology. 2014;81(3):149-59. doi: 10.1159/000358127. Epub 2014 Mar 14. Pathobiology. 2014. PMID: 24642775 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

76 results

Results by year